Zydus Lifesciences Ltd
NSE :ZYDUSLIFE BSE :532321 Sector : PharmaceuticalsBuy, Sell or Hold ZYDUSLIFE? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
08 May 1005.60 (2.52%) | 07 May 980.85 (-3.91%) | 06 May 1020.75 (2.34%) | 03 May 997.40 (0.95%) | 02 May 988.00 (3.61%) | 30 Apr 953.55 (-0.99%) | 29 Apr 963.10 (1.66%) | 26 Apr 947.40 (-0.40%) | 25 Apr 951.25 (1.90%) | 24 Apr 933.50 (-2.70%) | 23 Apr 959.45 (-0.03%) | 22 Apr 959.70 (4.07%) | 19 Apr 922.15 (-1.58%) | 18 Apr 937.00 (-0.83%) | 16 Apr 944.85 (1.04%) | 15 Apr 935.15 (-2.81%) | 12 Apr 962.15 (-3.22%) | 10 Apr 994.20 (0.51%) | 09 Apr 989.15 (-1.15%) | 08 Apr 1000.65 (-0.58%) | 05 Apr 1006.50 (2.37%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Neutral
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
998.5
10 DMA
Bullish
974.19
20 DMA
Bullish
967.2
50 DMA
Bullish
969.25
100 DMA
Bullish
855.07
200 DMA
Bullish
737.96
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 08, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1053.55 | 1030.4 | 1015.38 | - | - |
R2 | 1030.4 | 1016.82 | 1012.12 | 1033.09 | - |
R1 | 1018 | 1008.43 | 1008.86 | 1023.38 | 1024.2 |
P | 994.85 | 994.85 | 994.85 | 997.54 | 997.95 |
S1 | 982.45 | 981.27 | 1002.34 | 987.83 | 988.65 |
S2 | 959.3 | 972.88 | 999.08 | 961.99 | - |
S3 | 946.9 | 959.3 | 995.82 | - | - |
Key Metrics
EPS
26.71
P/E
37.65
P/B
6.93
Dividend Yield
0.6%
Market Cap
1,01,187 Cr.
Face Value
1
Book Value
145.11
ROE
14.05%
EBITDA Growth
1,160.9 Cr.
Debt/Equity
0.16
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Zydus Lifesciences Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 4296 | 5048.4 | 5175.6 | 4422.8 | 4564.7 |
PROFIT | 622.5 | 670.3 | 1095.43 | 801.7 | 767.8 |
EPS | 6.15 | 2.93 | 10.74 | 7.91 | 7.8 |
Zydus Lifesciences Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 2149.3 | 2830.5 | 3038.1 | 2693.8 | 2478.1 |
PROFIT | 255.9 | 651.55 | 780.9 | 805 | 450.4 |
EPS | 2.53 | 4.85 | 7.71 | 7.96 | 4.45 |
Profit & Loss (Figures in Rs. Crores)
Zydus Lifesciences Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 7344.2 | 8804.1 | 9553.5 | 9643.7 | 12333.5 | 13476.4 | 14460.8 | 14605.3 | 18055.3 | 17185.9 | |
PROFIT | 819.89 | 1157.11 | 1936.48 | 1488.67 | 1743.64 | 1793 | 1473.53 | 2369.75 | 4387.47 | 2387.89 | |
EPS | 7.75 | 10.9 | 18.76 | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 |
Zydus Lifesciences Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 4386.4 | 5545.6 | 7156.7 | 3960.8 | 6204.7 | 6728.6 | 7240.6 | 8017.6 | 8062.5 | 9174.9 | |
PROFIT | 905.37 | 1270.15 | 2038.39 | 662.54 | 1056.56 | 1411.26 | 1465.57 | 1633.15 | 1095.54 | 1621.61 | |
EPS | 8.82 | 11.97 | 19.9 | 6.45 | 10.65 | 14.51 | 13.8 | 14.42 | 8.38 | 15.11 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 17,414.6 | 16,897.2 | 12,889.9 | 10,273.3 | 10,283.9 | 8,642.1 | 6,857.6 | 5,596.8 | 4,149.2 | 3,336.6 |
Total Shareholders Funds | 17,515.8 | 16,999.6 | 12,992.3 | 10,375.7 | 10,386.3 | 8,744.5 | 6,960 | 5,699.2 | 4,251.6 | 3,439 |
Minority Interest | 2,172.5 | 2,054.2 | 1,937.3 | 1,334.7 | 1,292.9 | 191 | 156.1 | 135.8 | 168.9 | 144.3 |
Secured Loans | 0 | 500 | 383.9 | 1,873.2 | 2,585.7 | 481.2 | 1,197 | 689.8 | 1,169.1 | 1,271.6 |
Unsecured Loans | 1,194.9 | 3,720.9 | 4,223.7 | 6,113.2 | 5,313.7 | 4,925.5 | 4,010.2 | 1,752.2 | 1,482.2 | 1,428.8 |
Total Debt | 1,194.9 | 4,220.9 | 4,607.6 | 7,986.4 | 7,899.4 | 5,406.7 | 5,207.2 | 2,442 | 2,651.3 | 2,700.4 |
Other Liabilities | 327.2 | 382.8 | 349.5 | 282.3 | 259.4 | 209.6 | 214 | 157.3 | 132.5 | 130.9 |
Total Liabilities | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 | 6,414.6 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 18,343.8 | 17,650.9 | 17,345 | 16,781.5 | 15,702.3 | 9,349.1 | 8,102.9 | 5,767.3 | 5,138.5 | 4,664 |
Less: Accumulated Depreciation | 6,822.9 | 5,462.4 | 5,212.2 | 4,551 | 3,538.6 | 2,866.5 | 2,347.8 | 2,019.4 | 1,786.3 | 1,540.2 |
Net Block | 11,520.9 | 12,188.5 | 12,132.8 | 12,230.5 | 12,163.7 | 6,482.6 | 5,755.1 | 3,747.9 | 3,352.2 | 3,123.8 |
Capital Work in Progress | 1,200.7 | 725.9 | 783.2 | 741.5 | 837.2 | 1,527.2 | 1,543.3 | 950.8 | 797.9 | 891.5 |
Investments | 1,546.6 | 3,288 | 830.1 | 765 | 673.5 | 745.7 | 434.8 | 416.2 | 154.4 | 86.6 |
Inventories | 3,413.3 | 3,719.4 | 3,236.2 | 2,789 | 2,688 | 2,385.3 | 1,803.7 | 1,337.1 | 1,535.7 | 1,367.5 |
Sundry Debtors | 4,416.8 | 3,340.3 | 3,127.3 | 3,663.2 | 3,950.8 | 3,206.3 | 2,277.5 | 1,746.6 | 1,588.4 | 1,133.7 |
Cash and Bank Balance | 573.1 | 1,106.9 | 888.3 | 964.9 | 548.9 | 1,314.9 | 1,543.5 | 638.7 | 669.9 | 548.8 |
Loans and Advances | 985.7 | 1,575.4 | 1,265.3 | 1,085.5 | 1,080.5 | 1,048.4 | 348.5 | 358.9 | 311.5 | 323.5 |
Total Current Assets | 9,388.9 | 9,742 | 8,517.1 | 8,502.6 | 8,268.2 | 7,954.9 | 5,973.2 | 4,081.3 | 4,105.5 | 3,373.5 |
Current Liabilities | 3,829.4 | 3,576.7 | 3,460 | 3,225.3 | 3,203.4 | 3,079.2 | 2,498.1 | 1,834.1 | 1,398.8 | 1,181.9 |
Provisions | 522.2 | 407.4 | 418.3 | 272.3 | 189.4 | 152.2 | 68.9 | 81.3 | 382.5 | 292.7 |
Total Current Liabilities & Provisions | 4,351.6 | 3,984.1 | 3,878.3 | 3,497.6 | 3,392.8 | 3,231.4 | 2,567 | 1,915.4 | 1,784.2 | 1,475.8 |
Net Current Assets | 5,037.3 | 5,757.9 | 4,638.8 | 5,005 | 4,875.4 | 4,723.5 | 3,406.2 | 2,165.9 | 2,321.3 | 1,897.7 |
Deferred Tax Assets | 1,463.5 | 1,330.9 | 2,820.1 | 1,316.3 | 1,775.7 | 2,374.1 | 2,325.6 | 518.5 | 182.9 | 143 |
Deferred Tax Liability | 395.5 | 388.9 | 1,865.4 | 673.3 | 1,057.7 | 1,731.6 | 1,546.5 | 200.9 | 241.5 | 239.1 |
Net Deferred Tax | 1,068 | 942 | 954.7 | 643 | 718 | 642.5 | 779.1 | 317.6 | -58.6 | -96.1 |
Other Assets | 836.9 | 755.2 | 547.1 | 594.1 | 570.2 | 430.3 | 618.8 | 835.9 | 637.1 | 511.1 |
Total Assets | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 | 6,414.6 |
Contingent Liabilities | 801.1 | 666.7 | 668 | 673.8 | 459.9 | 291.5 | 199 | 234.1 | 163.7 | 248.7 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 13,538.2 | 13,138.1 | 12,642.1 | 11,157.8 | 8,466.8 | 7,643.1 | 6,515.9 | 6,173.8 | 4,423 | 3,527.5 |
Total Shareholders Funds | 13,639.4 | 13,240.5 | 12,744.5 | 11,260.2 | 8,569.2 | 7,745.5 | 6,618.3 | 6,276.2 | 4,525.4 | 3,629.9 |
Secured Loans | 0 | 500 | 383.9 | 356.9 | 319.4 | 246.8 | 961.4 | 453.7 | 922.9 | 1,035.4 |
Unsecured Loans | 4,825.3 | 2,164.7 | 3,536 | 3,337.8 | 3,263.9 | 2,625.7 | 1,978.4 | 769.1 | 526.8 | 550.8 |
Total Debt | 4,825.3 | 2,664.7 | 3,919.9 | 3,694.7 | 3,583.3 | 2,872.5 | 2,939.8 | 1,222.8 | 1,449.7 | 1,586.2 |
Other Liabilities | 166.2 | 191.3 | 179.2 | 132.7 | 114.5 | 82.8 | 70.3 | 110.4 | 84.4 | 67.4 |
Total Liabilities | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 | 5,283.5 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 7,989.6 | 7,675.6 | 7,009.1 | 6,564.2 | 6,152.3 | 4,515.7 | 3,896.3 | 3,720.5 | 3,118.9 | 2,683.7 |
Less : Accumulated Depreciation | 3,805.5 | 3,339.7 | 2,897.1 | 2,455.2 | 2,219.8 | 1,835.5 | 1,544.3 | 1,565.7 | 1,350.8 | 1,119.6 |
Net Block | 4,184.1 | 4,335.9 | 4,112 | 4,109 | 3,932.5 | 2,680.2 | 2,352 | 2,154.8 | 1,768.1 | 1,564.1 |
Capital Work in Progress | 739.3 | 384 | 570.5 | 552.6 | 674.9 | 659.2 | 678.4 | 296.8 | 366.9 | 530.6 |
Investments | 4,879.3 | 5,118 | 6,470.6 | 6,404.1 | 4,195.2 | 3,618.1 | 3,923.7 | 2,317.5 | 2,209.1 | 1,557.7 |
Inventories | 1,782.4 | 1,926.3 | 1,780 | 1,394.7 | 1,472.5 | 1,320.7 | 932.9 | 657.5 | 804.3 | 663.5 |
Sundry Debtors | 3,505.3 | 2,277.7 | 1,903.8 | 2,456.7 | 2,112.1 | 1,255.1 | 929 | 1,707.3 | 1,056.1 | 722 |
Cash and Bank Balance | 248.1 | 302.6 | 154 | 385.3 | 112.1 | 183.8 | 16.8 | 163.7 | 129.4 | 89.4 |
Loans and Advances | 1,420.8 | 2,110.3 | 2,193.9 | 556 | 560.6 | 797.8 | 260.7 | 293.9 | 249.2 | 296.8 |
Total Current Assets | 6,956.6 | 6,616.9 | 6,031.7 | 4,792.7 | 4,257.3 | 3,557.4 | 2,139.4 | 2,822.4 | 2,239 | 1,771.7 |
Current Liabilities | 1,539.3 | 1,384.5 | 1,401.7 | 1,195.1 | 1,157.9 | 1,217.3 | 1,283.7 | 1,074.3 | 814.8 | 585.3 |
Provisions | 199.1 | 105.9 | 111 | 70.5 | 89.6 | 52 | 29.8 | 54.9 | 339.5 | 250.7 |
Total Current Liabilities & Provisions | 1,738.4 | 1,490.4 | 1,512.7 | 1,265.6 | 1,247.5 | 1,269.3 | 1,313.5 | 1,129.2 | 1,154.3 | 836 |
Net Current Assets | 5,218.2 | 5,126.5 | 4,519 | 3,527.1 | 3,009.8 | 2,288.1 | 825.9 | 1,693.2 | 1,084.7 | 935.7 |
Deferred Tax Assets | 112 | 136.6 | 129.7 | 92.2 | 123.9 | 67 | 143.6 | 0 | 81.6 | 81.6 |
Deferred Tax Liability | 306.3 | 289.7 | 237 | 290.5 | 280.5 | 260.6 | 249.1 | 184.6 | 205.2 | 205.2 |
Net Deferred Tax | -194.3 | -153.1 | -107.3 | -198.3 | -156.6 | -193.6 | -105.5 | -184.6 | -123.6 | -123.6 |
Other Assets | 3,804.3 | 1,285.2 | 1,278.8 | 693.1 | 611.2 | 1,648.8 | 1,953.9 | 1,331.7 | 754.3 | 819 |
Total Assets | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 | 5,283.5 |
Contingent Liabilities | 319.9 | 1,797.1 | 1,503.9 | 3,690.3 | 3,100.3 | 2,563.3 | 2,292 | 1,417.2 | 1,296 | 1,194.5 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,582.7 |
Depreciation | 722.7 |
Interest (Net) | 49.8 |
Dividend Received | 1.1 |
P/L on Sales of Assets | -20.8 |
Prov. and W/O (Net) | -49.2 |
P/L in Forex | -312.1 |
Others | -863.2 |
Total Adjustments (PBT and Ext... | 933.9 |
Operating Profit before Workin... | 3,516.6 |
Trade and 0ther Receivables | -848.5 |
Inventories | 440.7 |
Trade Payables | -170.8 |
Total Adjustments (OP before W... | -235.8 |
Cash Generated from/(used in) ... | 3,280.8 |
Direct Taxes Paid | -592 |
Total Adjustments(Cash Generat... | -592 |
Cash Flow before Extraordinary... | 2,688.8 |
Net Cash from Operating Activi... | 2,688.8 |
Purchased of Fixed Assets | -1,030.9 |
Sale of Fixed Assets | 39.4 |
Sale of Investments | 1,784.3 |
Interest Received | 76.5 |
Cancellation of Investment in ... | 40 |
Net Cash used in Investing Act... | 1,177.8 |
Proceed from 0ther Long Term B... | 158.5 |
Of the Long Tem Borrowings | -996 |
Of the Short Term Borrowings | -2,306.4 |
Dividend Paid | -267.1 |
Interest Paid | -126.2 |
Net Cash used in Financing Act... | -4,400.4 |
Net Profit before Tax and Extr... | 2,032.2 |
Depreciation | 488.6 |
Interest (Net) | 98.4 |
Dividend Received | 240.1 |
P/L on Sales of Assets | -81 |
Prov. and W/O (Net) | -16.5 |
P/L in Forex | 47.3 |
Others | -863.2 |
Total Adjustments (PBT and Ext... | 475.1 |
Operating Profit before Workin... | 2,507.3 |
Trade and 0ther Receivables | -1,213.2 |
Inventories | 143.9 |
Trade Payables | -33.3 |
Total Adjustments (OP before W... | -1,035.9 |
Cash Generated from/(used in) ... | 1,471.4 |
Direct Taxes Paid | -393.2 |
Total Adjustments(Cash Generat... | -393.2 |
Cash Flow before Extraordinary... | 1,078.2 |
Net Cash from Operating Activi... | 1,078.2 |
Purchased of Fixed Assets | -750.1 |
Sale of Fixed Assets | 92.1 |
Sale of Investments | 35.6 |
Interest Received | 84 |
Loans to Subsidiaires | -2,314.8 |
Acquisition of Companies | -10 |
Net Cash used in Investing Act... | -1,959.7 |
Proceed from 0ther Long Term B... | 3,926.6 |
Of the Long Tem Borrowings | -746 |
Of the Short Term Borrowings | -1,093.4 |
Dividend Paid | -253.5 |
Interest Paid | -143.5 |
Net Cash used in Financing Act... | 827 |
Company Details
Registered Office |
|
Address | Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Registrars |
|
Address | Zydus Corporate Park S No 536 |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Management |
|
Name | Designation |
Pankaj R Patel | Chairman (Non-Executive) |
Sharvil P Patel | Managing Director |
Mukesh M Patel | Director |
Nitin Raojibhai Desai | Independent Director |
Dharmishta N Rawal | Independent Director |
Apurva S Diwanji | Independent Director |
Ganesh N Nayak | Executive Director |
Bhadresh K Shah | Independent Director |
Dhaval N Soni | Company Sec. & Compli. Officer |
Akhil A. Monappa | Independent Director |
Upasana Konidela. | Independent Director |